Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius kabi deutschland gmbh - germania - bendamustinum - pulb. pt. conc. pt. sol. perf. - 2,5mg/ml - agenti alchilanti analogi de nitrogen mustard

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

medochemie ltd. - factory c - cipru - cefazolinum - pulb. pt. sol. inj./perf. - 1g - alte antibiotice betalactamice cefalosporine de generatia i - a

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

accord healthcare polska sp. z.o.o. - ungaria - bendamustinum - pulb. pt. conc. pt. sol. perf. - 2,5mg/ml - agenti alchilanti analogi de nitrogen mustard

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

novo nordisk a/s - insulina aspart - diabetul zaharat - drugs used in diabetes, insulins and analogues for injection, fast-acting - tratamentul diabetului zaharat la adulți, adolescenți și copii cu vârsta de 1 an și peste.

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lipomed gmbh - germania - dacarbazinum - pulb. pt. sol. inj. sau perf. - 200mg - agenti alchilanti alti agenti alchilanti

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

thymoorgan pharmazie gmbh - germania - pemetrexedum - pulb. pt. conc. pt.sol. perf. - 500mg - antimetaboliti analogi ai acidului folic

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

acs dobfar s.p.a. - italia - meropenemum - pulb. pt. sol. inj./perf. - 1g - alte antibiotice betalactamice carbapeneme

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

acs dobfar s.p.a. - italia - meropenemum - pulb. pt. sol. inj./perf.  - 500mg - alte antibiotice betalactamice carbapeneme

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

labesfal-laboratÓrios almiro s.a. (fresenius kabi group) - portugalia - piperacillinum + tazobactamum - pulb. pt. sol. perf. - 2g/0,25g - antibiotice beta-lactamice, peniciline peniciline in combinatii incl. inhibitori de betalactamaza